These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11357168)

  • 21. Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-1ra Phase III Sepsis Syndrome Study Group.
    Knaus WA; Harrell FE; LaBrecque JF; Wagner DP; Pribble JP; Draper EA; Fisher CJ; Soll L
    Crit Care Med; 1996 Jan; 24(1):46-56. PubMed ID: 8565538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
    Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
    Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis.
    Cunnane G; Madigan A; Murphy E; FitzGerald O; Bresnihan B
    Rheumatology (Oxford); 2001 Jan; 40(1):62-9. PubMed ID: 11157143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group.
    Hickling P; Jacoby RK; Kirwan JR
    Br J Rheumatol; 1998 Sep; 37(9):930-6. PubMed ID: 9783756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial.
    Takeuchi T; Tanaka Y; Ishiguro N; Yamanaka H; Yoneda T; Ohira T; Okubo N; Genant HK; van der Heijde D
    Ann Rheum Dis; 2016 Jun; 75(6):983-90. PubMed ID: 26585988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of a pharmacogenomic response to interleukin-l receptor antagonist in rheumatoid arthritis.
    Camp NJ; Cox A; di Giovine FS; McCabe D; Rich W; Duff GW
    Genes Immun; 2005 Sep; 6(6):467-71. PubMed ID: 15931231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial.
    Wassenberg S; Rau R; Steinfeld P; Zeidler H
    Arthritis Rheum; 2005 Nov; 52(11):3371-80. PubMed ID: 16255011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anakinra.
    Cvetkovic RS; Keating G
    BioDrugs; 2002; 16(4):303-11; discussion 313-4. PubMed ID: 12196041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year.
    Kremer JM; Blanco R; Brzosko M; Burgos-Vargas R; Halland AM; Vernon E; Ambs P; Fleischmann R
    Arthritis Rheum; 2011 Mar; 63(3):609-21. PubMed ID: 21360490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing joint damage as the best measure of biologic drug therapy.
    Bresnihan B
    J Rheumatol Suppl; 2002 Sep; 65():39-43. PubMed ID: 12236622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis.
    McQueen FM; Benton N; Perry D; Crabbe J; Robinson E; Yeoman S; McLean L; Stewart N
    Arthritis Rheum; 2003 Jul; 48(7):1814-27. PubMed ID: 12847674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial.
    Genovese MC; Fleischmann R; Combe B; Hall S; Rubbert-Roth A; Zhang Y; Zhou Y; Mohamed MF; Meerwein S; Pangan AL
    Lancet; 2018 Jun; 391(10139):2513-2524. PubMed ID: 29908670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing radiographic status of rheumatoid arthritis: introduction of a short erosion scale.
    Wolfe F; van der Heijde DM; Larsen A
    J Rheumatol; 2000 Sep; 27(9):2090-9. PubMed ID: 10990218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal.
    Paulus HE; Oh M; Sharp JT; Gold RH; Wong WK; Park GS; Bulpitt KJ;
    Arthritis Rheum; 2004 Apr; 50(4):1083-96. PubMed ID: 15077290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anakinra as a new therapeutic option in rheumatoid arthritis: clinical results and perspectives.
    Bresnihan B
    Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S32-4. PubMed ID: 14989427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.
    Fisher CJ; Dhainaut JF; Opal SM; Pribble JP; Balk RA; Slotman GJ; Iberti TJ; Rackow EC; Shapiro MJ; Greenman RL
    JAMA; 1994 Jun; 271(23):1836-43. PubMed ID: 8196140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
    Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computer-based methods for measuring joint space and estimating erosion volume in the finger and wrist joints of patients with rheumatoid arthritis.
    Sharp JT; Gardner JC; Bennett EM
    Arthritis Rheum; 2000 Jun; 43(6):1378-86. PubMed ID: 10857798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and radiological effects of anakinra in patients with rheumatoid arthritis.
    Bresnihan B; Cobby M
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii22-8. PubMed ID: 12817092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting.
    Sanmarti R; Gomez A; Ercilla G; Gratacos J; Larrosa M; Suris X; Vinas O; Salvador G; Munoz-Gomez J; Canete JD
    Rheumatology (Oxford); 2003 Sep; 42(9):1044-9. PubMed ID: 12730518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.